These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24276952)

  • 1. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.
    Ripamonti CI; Bandieri E; Pessi MA; Maruelli A; Buonaccorso L; Miccinesi G
    Support Care Cancer; 2014 Mar; 22(3):783-93. PubMed ID: 24276952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety.
    Vignaroli E; Pace EA; Willey J; Palmer JL; Zhang T; Bruera E
    J Palliat Med; 2006 Apr; 9(2):296-303. PubMed ID: 16629559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of anxiety and depression and screening performance of the Edmonton Symptom Assessment Scale in a psycho-oncology clinic.
    Valentine A; Brown J; Lacourt T; Chen M; De La Garza R; Bruera E
    Psychooncology; 2022 Feb; 31(2):290-297. PubMed ID: 34546618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
    Kwon JH; Nam SH; Koh S; Hong YS; Lee KH; Shin SW; Hui D; Park KW; Yoon SY; Won JY; Chisholm G; Bruera E
    J Pain Symptom Manage; 2013 Dec; 46(6):947-56. PubMed ID: 23628516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression.
    Bagha SM; Macedo A; Jacks LM; Lo C; Zimmermann C; Rodin G; Li M
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):60-9. PubMed ID: 22694595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between malnutrition risk and revised Edmonton Symptom Assessment System (ESAS-r) scores in an adult outpatient oncology population: a cross-sectional study.
    McLay K; Stonewall N; Forbes L; Peters C
    J Patient Rep Outcomes; 2024 Jul; 8(1):71. PubMed ID: 38995461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Edmonton Symptom Assessment Scale.
    Chang VT; Hwang SS; Feuerman M
    Cancer; 2000 May; 88(9):2164-71. PubMed ID: 10813730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer.
    Brenne E; Loge JH; Lie H; Hjermstad MJ; Fayers PM; Kaasa S;
    Palliat Med; 2016 Jun; 30(6):587-98. PubMed ID: 26763008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.
    Mercadante S; Adile C; Ferrera P; Cortegiani A; Casuccio A
    Oncologist; 2019 Jun; 24(6):e358-e364. PubMed ID: 30355776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Accuracy of the Edmonton Symptom Assessment System for the Assessment of Depression in Patients With Cancer: A Systematic Review and Meta-Analysis.
    Boonyathee S; Nagaviroj K; Anothaisintawee T
    Am J Hosp Palliat Care; 2018 Apr; 35(4):731-739. PubMed ID: 29186983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Daytime Activity, Fatigue, Sleep, Anxiety, Depression, and Symptom Burden in Advanced Cancer Patients: A Preliminary Report.
    Yennurajalingam S; Tayjasanant S; Balachandran D; Padhye NS; Williams JL; Liu DD; Frisbee-Hume S; Bruera E
    J Palliat Med; 2016 Aug; 19(8):849-56. PubMed ID: 27148765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden.
    Tanco K; Vidal M; Arthur J; Delgado Guay M; Hui D; Liu D; Chisholm G; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):14-22. PubMed ID: 28264740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting.
    Delgado-Guay M; Parsons HA; Li Z; Palmer JL; Bruera E
    Support Care Cancer; 2009 May; 17(5):573-9. PubMed ID: 19005686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the French Version of the Edmonton Symptom Assessment System.
    Pautex S; Vayne-Bossert P; Bernard M; Beauverd M; Cantin B; Mazzocato C; Thollet C; Bollondi-Pauly C; Ducloux D; Herrmann F; Escher M
    J Pain Symptom Manage; 2017 Nov; 54(5):721-726.e1. PubMed ID: 28751077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
    Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
    Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
    Chow S; Wan BA; Pidduck W; Zhang L; DeAngelis C; Chan S; Yee C; Drost L; Leung E; Sousa P; Lewis D; Lam H; Chow R; Lock M; Chow E
    Clin Breast Cancer; 2019 Dec; 19(6):405-410. PubMed ID: 31182402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer.
    Salvo N; Zeng L; Zhang L; Leung M; Khan L; Presutti R; Nguyen J; Holden L; Culleton S; Chow E
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):139-48. PubMed ID: 21652191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
    Moskovitz M; Jao K; Su J; Brown MC; Naik H; Eng L; Wang T; Kuo J; Leung Y; Xu W; Mittmann N; Moody L; Barbera L; Devins G; Li M; Howell D; Liu G
    Curr Oncol; 2019 Dec; 26(6):e733-e741. PubMed ID: 31896943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer.
    Delgado-Guay M; Yennurajalingam S; Parsons H; Palmer JL; Bruera E
    J Pain Symptom Manage; 2011 May; 41(5):819-27. PubMed ID: 21306864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.